| Dr Dennis Hamilton Goldsberry, MD | |
|
5225 Independence Pkwy, Suite 100, Frisco, TX 75035 | |
| (972) 215-7500 | |
| (972) 432-5164 |
| Full Name | Dr Dennis Hamilton Goldsberry |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 23 Years |
| Location | 5225 Independence Pkwy, Frisco, Texas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942228614 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 036113336 (Illinois) | Secondary |
| 207W00000X | Ophthalmology | M4099 (Texas) | Primary |
| Entity Name | Dennis H. Goldsberry, M.d., Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265755193 PECOS PAC ID: 5799813663 Enrollment ID: O20100513000707 |
News Archive
Regions Hospital reported $49 million in community benefit in 2011. Regions calculates community benefit by using standards set by the Catholic Health Association and used by the Internal Revenue Service for nonprofit hospitals filing Form 990.
GOP leaders face various challenges in their strategy to repeal the health law.
Health insurance policies in California will have to cover all federally approved contraceptives for women by 2016 without charging co-payments under legislation signed this week by Gov. Jerry Brown, countering trends in other states and the U.S. Supreme Court. The bill, SB1053 by Sen. Holly Mitchell, D-Los Angeles, expands state laws that required coverage for most birth-control drugs and devices approved by the U.S. Food and Drug Administration. The new law mandates coverage for all FDA-approved contraception, prohibits co-payments and includes managed-care Medi-Cal plans, which are not expressly covered by current laws (Egelko, 9/27).
A team of researchers at Umea University in Sweden under the leadership of Thomas Edlund, Umea Center for Molecular Medicine, is now publishing their discovery of the signal molecules that regulate the formation of spinal marrow during the fetal period.
Depomed, Inc. today announced that it has received a $10 million milestone payment from Abbott Products, Inc., its licensee of DM-1796, for the U.S. Food and Drug Administration's acceptance for filing of the New Drug Application (NDA) for DM-1796 for the management of postherpetic neuralgia (PHN), or pain after shingles.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dennis Hamilton Goldsberry, MD 5225 Independence Pkwy, Suite 100, Frisco, TX 75035-4651 Ph: (972) 215-7500 | Dr Dennis Hamilton Goldsberry, MD 5225 Independence Pkwy, Suite 100, Frisco, TX 75035 Ph: (972) 215-7500 |
News Archive
Regions Hospital reported $49 million in community benefit in 2011. Regions calculates community benefit by using standards set by the Catholic Health Association and used by the Internal Revenue Service for nonprofit hospitals filing Form 990.
GOP leaders face various challenges in their strategy to repeal the health law.
Health insurance policies in California will have to cover all federally approved contraceptives for women by 2016 without charging co-payments under legislation signed this week by Gov. Jerry Brown, countering trends in other states and the U.S. Supreme Court. The bill, SB1053 by Sen. Holly Mitchell, D-Los Angeles, expands state laws that required coverage for most birth-control drugs and devices approved by the U.S. Food and Drug Administration. The new law mandates coverage for all FDA-approved contraception, prohibits co-payments and includes managed-care Medi-Cal plans, which are not expressly covered by current laws (Egelko, 9/27).
A team of researchers at Umea University in Sweden under the leadership of Thomas Edlund, Umea Center for Molecular Medicine, is now publishing their discovery of the signal molecules that regulate the formation of spinal marrow during the fetal period.
Depomed, Inc. today announced that it has received a $10 million milestone payment from Abbott Products, Inc., its licensee of DM-1796, for the U.S. Food and Drug Administration's acceptance for filing of the New Drug Application (NDA) for DM-1796 for the management of postherpetic neuralgia (PHN), or pain after shingles.
› Verified 7 days ago
Mahdi Rostamizadeh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11500 State Hwy 121, Unite #720, Frisco, TX 75035 Phone: 732-890-7885 | |
Jessica Nichole Thayer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 12400 Dallas Pkwy, Frisco, TX 75033 Phone: 214-645-2020 | |
Jay Leonard Merten, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7179 Drummond Dr, Frisco, TX 75035 Phone: 214-418-3773 |